Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2022
Estimating prevalence of early Alzheimer's disease in the United States, accounting for racial and ethnic diversityCai Gillis, Philip Montenigro, Mina Nejati, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 25, 2010
Methodological considerations with the use of urine samples for assessment of mercury excretion and markers of renal damageFelicia Trachtenberg, Lars Barregard, Nancy Maserejian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 3, 2021
Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosisNancy Maserejian, Henry Krzywy, Susan Eaton, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2019
The incidence of mild cognitive impairment: A systematic review and data synthesisCai Gillis, Fariba Mirzaei, Michele Potashman, et al.
Journal of Alzheimer'S Disease : JAD|December 28, 2020
Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart StudyJing Yuan, Nancy Maserejian, Yulin Liu, et al.
Parkinsonism & Related Disorders|June 2, 2022
Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive reviewChristopher Simpson, Lisa Vinikoor-Imler, Feiby L Nassan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2019
Practical algorithms for amyloid β probability in subjective or mild cognitive impairmentNancy Maserejian, Shijia Bian, Wenting Wang, et al.
Frontiers in Neurology|October 2, 2019
Associating Cognition With Amyloid Status Using Partially Ordered Set AnalysisSarah J A Carr, Judith Jaeger, Shijia Bian, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Pageof 1